Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $57.7 million.

  • Mimedx's Total Current Liabilities rose 3753.13% to $57.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.7 million, marking a year-over-year increase of 3753.13%. This contributed to the annual value of $45.6 million for FY2024, which is 89.77% down from last year.
  • Mimedx's Total Current Liabilities amounted to $57.7 million in Q3 2025, which was up 3753.13% from $50.3 million recorded in Q2 2025.
  • Mimedx's Total Current Liabilities' 5-year high stood at $57.7 million during Q3 2025, with a 5-year trough of $36.6 million in Q1 2022.
  • Moreover, its 5-year median value for Total Current Liabilities was $43.6 million (2022), whereas its average is $44.7 million.
  • As far as peak fluctuations go, Mimedx's Total Current Liabilities tumbled by 3396.44% in 2022, and later skyrocketed by 3753.13% in 2025.
  • Over the past 5 years, Mimedx's Total Current Liabilities (Quarter) stood at $42.4 million in 2021, then grew by 2.83% to $43.6 million in 2022, then increased by 5.63% to $46.0 million in 2023, then decreased by 0.9% to $45.6 million in 2024, then rose by 26.51% to $57.7 million in 2025.
  • Its Total Current Liabilities was $57.7 million in Q3 2025, compared to $50.3 million in Q2 2025 and $42.6 million in Q1 2025.